Rosiglitazone Inhibits Bone Regeneration and Causes Significant Accumulation of Fat at Sites of New Bone Formation
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rosiglitazone Inhibits Bone Regeneration and Causes Significant Accumulation of Fat at Sites of New Bone Formation
Authors
Keywords
-
Journal
CALCIFIED TISSUE INTERNATIONAL
Volume 91, Issue 2, Pages 139-148
Publisher
Springer Nature
Online
2012-06-30
DOI
10.1007/s00223-012-9623-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Beyond VEGF: Inhibition of the Fibroblast Growth Factor Pathway and Antiangiogenesis
- (2011) C. Lieu et al. CLINICAL CANCER RESEARCH
- PDGF in bone formation and regeneration: New insights into a novel mechanism involving MSCs
- (2011) Arnold I. Caplan et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- The Peroxisome Proliferator-Activated Receptor-γ Agonist Rosiglitazone Increases Bone Resorption in Women with Type 2 Diabetes: A Randomized, Controlled Trial
- (2010) Ugis Gruntmanis et al. CALCIFIED TISSUE INTERNATIONAL
- PGC1β Mediates PPARγ Activation of Osteoclastogenesis and Rosiglitazone-Induced Bone Loss
- (2010) Wei Wei et al. Cell Metabolism
- PPARγ in Placental Angiogenesis
- (2010) Karim Nadra et al. ENDOCRINOLOGY
- Thiazolidinedione Use and the Longitudinal Risk of Fractures in Patients with Type 2 Diabetes Mellitus
- (2010) Zeina A. Habib et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bone Marrow Fat Is Inversely Related to Cortical Bone in Young and Old Subjects
- (2010) Tishya A. L. Wren et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mesenchymal Stem Cells Expressing Osteogenic and Angiogenic Factors Synergistically Enhance Bone Formation in a Mouse Model of Segmental Bone Defect
- (2010) Sanjay Kumar et al. MOLECULAR THERAPY
- Bone Loss in Diabetes: Use of Antidiabetic Thiazolidinediones and Secondary Osteoporosis
- (2010) Beata Lecka-Czernik Current Osteoporosis Reports
- PPARs in Bone: The Role in Bone Cell Differentiation and Regulation of Energy Metabolism
- (2010) Beata Lecka-Czernik Current Osteoporosis Reports
- Drilled Hole Defects in Mouse Femur as Models of Intramembranous Cortical and Cancellous Bone Regeneration
- (2009) Laurent Monfoulet et al. CALCIFIED TISSUE INTERNATIONAL
- PPARγ2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells
- (2009) Keith R. Shockley et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
- (2009) Bernard Zinman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Molecular Mechanisms Controlling Bone Formation during Fracture Healing and Distraction Osteogenesis
- (2009) Z.S. AI-Aql et al. JOURNAL OF DENTAL RESEARCH
- Fat and Beyond: The Diverse Biology of PPARγ
- (2008) Peter Tontonoz et al. Annual Review of Biochemistry
- Use of Thiazolidinediones and Fracture Risk
- (2008) Christian Meier et al. ARCHIVES OF INTERNAL MEDICINE
- Diabetes and Its Complications and Their Relationship with Risk of Fractures in Type 1 and 2 Diabetes
- (2008) Peter Vestergaard et al. CALCIFIED TISSUE INTERNATIONAL
- Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis
- (2008) Y. K. Loke et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)
- (2008) S. E. Kahn et al. DIABETES CARE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now